Drug resistance, antibiotics, superbugs | Homeland Security Newswire

SuperbugsSynthetic virus tackles antimicrobial resistance

Published 25 January 2018

Antibiotic resistance has become an ever-growing global challenge, with more than 700,000 people across the world dying from drug resistant infections every year. As a result, antibiotic discovery has fallen well behind its historical rate, with traditional discovery methods being exhausted. Scientists have engineered a brand new artificial virus that kills bacteria on first contact. This new virus is built using the same geometric principles that determine structures of naturally occurring viruses, known as polyhedral capsids.

Antibiotic resistance has become an ever-growing global challenge, with more than 700,000 people across the world dying from drug resistant infections every year. As a result, antibiotic discovery has fallen well behind its historical rate, with traditional discovery methods being exhausted. The U.K. National Physical Laboratory (NPL) says it is addressing technology and innovation challenges in response to this, including support for the implementation of synthetic/engineering biology.

NPL says that in line with NPL’s approach to addressing the global threat of antimicrobial resistance by helping to develop new antibiotics, a team of researchers from NPL and University College London (UCL) have engineered a purely artificial virus, which has the ability to kill bacteria on contact.

The resulting synthetic virus acts as a 20-nm spherical “drone”’ that, upon recognizing bacterial cells, attacks their cell walls with bullet speed and efficacy.

In contrast to a traditional antibiotic, these artificial viruses tackle a bacterium as a whole, starting with the disruption of the most complex, but vulnerable part of a bacterial cell – its membrane. This provides an advantage over an antibiotic, which must reach and hit its single target inside a bacterial cell to be effective.

This of action means that bacteria are less likely to become resistant to the virus – opening the door to potentially more effective treatments of resistant bacteria.

Furthermore, because such viruses leave human cells unaffected, but have the ability to infect them like viruses do, they hold promise for gene delivery and gene editing – core capabilities for gene therapy and synthetic biology – as well as for killing bacteria that hide inside human cells.

Max Ryadnov, Science Leader in Biometrology at NPL, said: “This work adds to the growing toolbox of engineering metrology methods and materials being developed at NPL to realize the full potential of synthetic biology for industry and healthcare. The research may also offer long-term and creative solutions for alternative treatments of infectious diseases that are urgently needed.”

Bart Hoogenboom, Professor of Biophysics at UCL, said: “When we exposed bacterial model membranes to these synthetic viruses in our experiments, the results were devastating: within a few minutes, the membranes were completely destroyed.”

The findings pave the way for exemplar synthetic biology tools for research and therapeutic use, while demonstrating how effective innovative measurement can be in addressing real-life challenges.

NPL notes that it is also supporting the advancement of synthetic biology through a new £7 million virtual lab to underpin the Center for Engineering Biology, Metrology and Standards, with LGC, NIBSC, and Imperial College London’s SynbiCITE. This new lab aims to improve the reproducibility of research results to help convert innovation in synthetic biology into valuable products and services.

— Read more in Emiliana De Santis et al., “Antimicrobial peptide capsids of de novo design,” Nature Communications 8, Article number: 2263 (22 December 2017) (DOI: 10.1038/s41467-017-02475-3